Biocon’s Nepexto Lands in Australia — A New Chapter in Biologics Begins

Unknown Apr 02, 2026 1,000 Views

1. Strategic Expansion into Advanced Markets Biocon Biologics has officially launched Nepexto, its etanercept biosimilar, in Australia, marking a key milestone in its global rollout strategy. - Nepexto is indicated for autoimmune conditions including rheumatoid arthr...